ENDLOS-TURBO PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 11:34:26 2024-06-24 am EDT | ||
| 4.45 EUR | -8.06% |
|
| Current month | +3.20% | ||
| 1 month | +11.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-24 | 4.45 | -8.06% |
| 24-06-21 | 4.84 | +4.99% |
| 24-06-20 | 4.61 | -6.87% |
| 24-06-19 | 4.95 | +2.91% |
| 24-06-18 | 4.81 | +6.42% |
Delayed Quote Deutsche Boerse AG
Last update June 24, 2024 at 11:34 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ2AM2 |
| ISIN | DE000DJ2AM28 |
| Date issued | 2023-09-08 |
| Strike | 272.6 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.614 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8 € |
|---|---|
| Lowest since issue | 0.51 € |
| Spread | 0.01 € |
| Spread % | 0.22% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
224
USD
Average target price
284.6
USD
Spread / Average Target
+27.07%
- Stock Market
- Certificates
- Certificat
